MiMedx Group Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +11.9% | +26.8% | +163.9% | -43.1% | +0.0% | -210.1% | – | – | – | +147.2% | +11.8% | |
| – | +28.6% | +100.2% | +5.4% | +20.0% | +0.0% | +9.7% | -31.7% | -21.9% | -15.3% | +76.3% | +146.3% | |
| – | +47.5% | +4.9% | +19.5% | – | – | -18.3% | +17.3% | -10.5% | +33.9% | -0.2% | -3.2% | |
| – | -23.4% | -13.1% | -162.3% | – | -71.9% | +85.7% | -27.0% | +4.2% | – | – | – | |
| – | – | – | -108.4% | – | – | -207.8% | – | – | – | – | – | |
| – | +127.8% | +6.5% | -17.4% | +83.7% | +0.0% | -76.5% | +45.1% | -16.6% | -26.0% | -15.3% | -38.6% | |
| – | -94.4% | +1,622.4% | -53.8% | +70.8% | +0.0% | -50.6% | -25.5% | -21.6% | -19.0% | +344.7% | -28.1% | |
| – | – | – | – | – | – | – | -98.6% | -54.7% | +53.1% | – | – | |
| – | +617.7% | -71.3% | +526.7% | -94.4% | +210.8% | -88.2% | +222.3% | -75.0% | +699.6% | -72.2% | +18.1% | |
| – | +430.8% | -83.6% | -71.6% | -89.7% | – | -145.2% | -99.9% | +7.9% | -100.0% | – | -96.8% | |
| – | +1,588.0% | -77.5% | +640.9% | -85.2% | +0.0% | – | -105.3% | -82.7% | +1,377.6% | +299.1% | -84.2% | |
| – | -822.7% | – | -170.8% | – | +0.0% | +35.8% | -136.4% | – | – | +39.7% | +175.3% | |
| – | -8.9% | +35.9% | +227.7% | -55.4% | +2.4% | -257.8% | – | – | – | +160.3% | +13.1% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.